Project Costs,"Year ended December 31,",Increase
(In millions),2009,2008,(Decrease)
ARCALYSTÂ®,$67.7,$39.2,$28.5
VEGF Trap-Eye,109.8,82.7,27.1
Aflibercept,23.3,32.1,(8.8)
REGN88,36.9,21.4,15.5
Other antibody candidates in clinical development,74.4,27.4,47.0
Other research programs & unallocated costs,86.7,72.1,14.6
Total research and development expenses,$398.8,$274.9,$123.9
